Remedis

Remedis is a Polish medical technology and biotechnology company specializing in the development and manufacturing of innovative biomaterials for advanced wound care and tissue regeneration. The company's core expertise lies in its proprietary Rem-Algin technology, which utilizes specialized alginate-based hydrogels to create a moist environment conducive to healing while providing antimicrobial properties. Remedis offers a range of professional wound dressings designed to treat complex, non-healing chronic wounds such as diabetic foot ulcers and pressure sores. Beyond wound care, the company explores the application of its biomaterial platforms in surgical sealants and drug delivery systems. Remedis is publicly traded on the NewConnect market of the Warsaw Stock Exchange.